Greg H. Tesch
Clayton, VIC, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
A new Jun amino-terminal kinase inhibitor, KRev-202, inhibits rat ischemic acute injury and the progression to renal fibrosis.
Journal: Frontiers in pharmacology
Published: July 16, 2025
A randomized controlled trial of intravenous immunoglobulin vs standard of care for the treatment of chronic active antibody-mediated rejection in kidney transplant recipients.
Journal: Kidney international
Published: March 16, 2025
Cellular delivery of relaxin-2 mRNA as a potential treatment for kidney fibrosis.
Journal: Materials today. Bio
Published: January 11, 2023
Corrigendum: c-Jun amino terminal kinase signaling promotes aristolochic acid-induced acute kidney injury.
Journal: Frontiers in physiology
Published: December 14, 2022
Mice with Established Diabetes Show Increased Susceptibility to Renal Ischemia/Reperfusion Injury: Protection by Blockade of Jnk or Syk Signaling Pathways.
Journal: The American journal of pathology
Published: September 01, 2021
WNT1-inducible signaling pathway protein 1 regulates kidney inflammation through the NF-κB pathway.
Journal: Clinical science (London, England : 1979)
Published: July 03, 2021
Review article: Have emergency department time-based targets influenced patient care? A systematic review of qualitative literature.
Journal: Emergency medicine Australasia : EMA
Published: January 19, 2021
c-Jun Amino Terminal Kinase Signaling Promotes Aristolochic Acid-Induced Acute Kidney Injury.
Journal: Frontiers in physiology
Published: August 26, 2020
Targeting apoptosis signal-regulating kinase 1 in acute and chronic kidney disease.
Journal: Anatomical record (Hoboken, N.J. : 2007)
Published: August 22, 2019
Establishing equivalent diabetes in male and female Nos3-deficient mice results in a comparable onset of diabetic kidney injury.
Journal: Physiological reports
Published: May 24, 2019
Pharmacological inhibition of protease-activated receptor-2 reduces crescent formation in rat nephrotoxic serum nephritis.
Journal: Clinical and experimental pharmacology & physiology
Published: January 08, 2019
ASK1 inhibitor treatment suppresses p38/JNK signalling with reduced kidney inflammation and fibrosis in rat crescentic glomerulonephritis.
Journal: Journal of cellular and molecular medicine
Published: February 14, 2018
Last Updated: 09/26/2026